Riccardo LoCascio
Head of Partnerships & Strategic Accounts (Advanced Proteins) Novonesis
Seminars
Thursday 11th June 2026
Closing Panel: Decision Criteria for New Ingredients Shaping the Future of Formula
2:30 pm
- Gain a clear, end-to-end view of how novel ingredients are evaluated, from first screening through pilot trials to full commercial adoption, and what determines decisions
- Define the evidence that moves the market, understanding the evidence package required to advance ingredients, including regulatory readiness, clinical validation, functional performance, and supply security
- Align on realistic timelines and economics, from initial engagement to revenue generation, helping innovators and partners plan investment and scale appropriately
- Set shared priorities for accelerating innovation, synthesize summit insights into actionable industry priorities
